Healthcare -
Biotechnology - NASDAQ - US
$ 1.85
-0.538 %
$ 523 M
Market Cap
-2.34
P/E
ERAS - STOCK-BASED COMPENSATION
Stock-based Compensation ERAS - Erasca, Inc.
26.2 M
LAST VALUE
77.44%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR